Bank of America’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Bank of America’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-61,666	Closed	-$2.22M	–	8671
2022 Q4	$2.22M	Buy	61,666 +56,995	+1,220%	+$1.43M	﹤0.01%	4162
2022 Q3	$71K	Sell	4,671 -3,880	-45%	-$62.9K	﹤0.01%	6516
2022 Q2	$115K	Sell	8,551 -10,985	-56%	-$174K	﹤0.01%	6404
2022 Q1	$377K	Buy	19,536 +13,394	+218%	+$278K	﹤0.01%	6026
2021 Q4	$145K	Buy	6,142 +5,288	+619%	+$123K	﹤0.01%	6684
2021 Q3	$18K	Buy	+854	New	+$18.3K	﹤0.01%	7430

Bank of America's IMGO Position: Q1 2023 in Review

Bank of America sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 61,666 shares — an estimated $2.22M sold.

Bank of America first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $2.22M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Bank of America reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Bank of America sold 61,666 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $2.22M.
Bank of America first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 6 quarters.
Bank of America's Imago BioSciences, Inc. Common stock position peaked at $2.22M in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Bank of America's 13F filing for Q1 2023, filed 12 May 2023.